UroGen Pharma Ltd. (URGN) stock
URGNNasdaqPharmaceutical PreparationsFiscal year ends December 31
$29.87+1.77 (+6.30%)
Close on Nov 17, 2026Market cap $1.46BP/E –Yield –
UroGen Pharma enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
UroGen Pharma's enterprise value was $1.36B on Nov 11, 2026, against $1.34B a year earlier. Over the last 5 years it ranged from $54.37M to $2.19B, with a median of $406.06M.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $1.36B | +24.4% |
| 2025 | Dec 31, 2025 | $1.09B | +244.1% |
| 2024 | Dec 31, 2024 | $316.84M | -45.1% |
| 2023 | Dec 29, 2023 | $577.62M | +220.8% |
| 2022 | Dec 30, 2022 | $180.08M | +75.2% |
| 2021 | Dec 31, 2021 | $102.77M | -63.0% |
| 2020 | Dec 31, 2020 | $278.10M | -48.6% |
| 2019 | Dec 31, 2019 | $540.72M | -7.4% |
| 2018 | Dec 31, 2018 | $583.88M | +806.2% |
| 2017 | Dec 29, 2017 | $64.43M | – |
See a number that looks wrong?